...
首页> 外文期刊>Rheumatology International >Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus
【24h】

Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus

机译:系统性红斑狼疮患者外周血中调节性T细胞的定量

获取原文
获取原文并翻译 | 示例
           

摘要

Regulatory T cells (Tregs) are supposed to stop immune responses in the course of immune activation. However, chronic activation of immune system in systemic lupus erythematosus (SLE) and many other autoreactive disorders are evidence of malfunction of this system. Therefore, it is plausible to quantify presence of these cells in different diseases. Forty-one patients with diagnosis of SLE were enrolled in this study. Patients were divided into two groups of patients with active and inactive disease based on the disease activity score. Flow cytometry analysis was used to determine the frequency of regulatory T cells in peripheral blood according to high expression of CD25 and intracellular Forkhead/winged-helix (Foxp3). Further 30 healthy individuals considered as control group. Significantly less CD4+CD25hi regulatory T cells were detected in active patients (P 0.001) compared to healthy individuals. The percentage of CD4+CD25hi cells were inversely correlated with the SLEDAI disease score in patients with active disease (r = −0.837, P 0.0001). Patients with active disease had lower frequencies of CD4+Foxp3+ cells. However, increased frequencies of CD4+Foxp3+ T cells were observed in peripheral blood of patients with inactive disease compared with active patients or healthy individuals (P 0.010). Moreover, a significant difference between the proportion of CD4+CD25-Foxp3+ population in healthy controls and patients with active disease was shown (P 0.0005). Presence of lower frequencies of Tregs in patients with SLE could be evaluated as an immune turbulence and could be employed as a target for immunotherapeutic manipulation. However, controversies need to be resolved.
机译:调节性T细胞(Tregs)应该在免疫激活过程中停止免疫反应。但是,系统性红斑狼疮(SLE)和许多其他自身反应性疾病中免疫系统的慢性激活是该系统功能障碍的证据。因此,量化这些细胞在不同疾病中的存在是合理的。本研究纳入了41例诊断为SLE的患者。根据疾病活动评分,将患者分为活动性和非活动性疾病两组。流式细胞仪分析用于确定外周血中调节性T细胞的频率,这取决于CD25和细胞内前叉/翼状螺旋(Foxp3)的高表达。另外30个健康个体被认为是对照组。与健康个体相比,在活动患者中检测到的CD4 + CD25hi调节性T细胞少得多(P <0.001)。患有活动性疾病的患者中CD4 + CD25hi细胞的百分比与SLEDAI疾病得分呈负相关(r = -0.837,P <0.0001)。活动性疾病患者的CD4 + Foxp3 +细胞频率较低。然而,与活跃患者或健康个体相比,非活跃疾病患者外周血中CD4 + Foxp3 + T细胞的频率增加(P <0.010)。此外,在健康对照和患有活动性疾病的患者中,CD4 + CD25-Foxp3 +人口比例之间存在显着差异(P <0.0005)。 SLE患者中Treg频率较低的情况可评估为免疫紊乱,并可作为免疫治疗操作的靶点。但是,争议需要解决。

著录项

  • 来源
    《Rheumatology International》 |2011年第9期|p.1219-1225|共7页
  • 作者单位

    Immunotherapy Laboratory, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;

    Department of Rheumatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;

    Gene Therapy Laboratory, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran;

    Department of Rheumatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Autoimmune disease; SLE; Treg;

    机译:自身免疫性疾病;SLE;Treg;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号